David W. Morledge, MD
David W. Morledge, MD, received his medical degree in 1986 from Texas Tech University Health Science Center in Lubbock, where he also completed an internship in Internal Medicine. During his residency in Neurology at Arizona Health Science Center, Dr. Morledge served as Chief Resident. He has held leadership positions in the field of neurology including Chairman of the Department of Neurosurgery/Neurology and Chief of Neurology/Neurosurgery for St. David’s Medical Center; member of the Medical Advisory Board for the National Multiple Sclerosis Society, Lone Star Chapter; and Medical Director of the Brain Injury Program at Texas Neuro Rehab Hospital. Dr. Morledge has been voted a Texas Monthly magazine Texas Super Doctor (2004-2009).
A devoted researcher, Dr. Morledge’s works have appeared in medical journals. At the University of Texas Medical Branch in Galveston, he served as a Clinical Assistant Professor in the Department of Neurology. Dr. Morledge was raised in Houston, and received his Bachelor of Arts in Biology (with Honors) from the University of Texas at Austin.
Curriculum vitae of Dr. David W. Morledge, MD (PDF)
Education:
Neurology, 1987-1990
Arizona Health Science Center
Internship, Internal Medicine, 1986-1987
Texas Tech University
Lubbock, Texas
Doctor of Medicine, 1982-1986
Texas Tech University Health Science Center Lubbock, Texas
Bachelor of Arts, with honors, Biology University of Texas, 1977-1981
Austin, Texas
Clinical Appointments
Neurologist, 1990 - Present
Austin Neurological Clinic Austin, Texas
Medical Advisory Board, 2005 - Present
National Multiple Sclerosis Society
Lone Star Chapter
Austin, Texas
Medical Director of Brain Injury Program, 2004 - Present
Texas Neuro Rehab Hospital
Austin, Texas
Clinical Assistant Professor, 2005 - 2006
Department of Neurology UTMB
Galveston, Texas
Chief of Neurology/Neurosurgery Department, 1997 - 1998
St. David’s Medical Center Austin, Texas
Licensure & Board Certification
License - Texas
America Board of
FLEX, 1986
Honors and Awards
Voted Texas Super Doctor, Texas Monthly Magazine, 2004-2009 Austin, Texas
Dean’s Honor List, University of Texas, 1980
Austin, Texas
Professional Organizations
Texas Medical Association
Texas Neurological Society
Travis County Medical Society
American Academy of Neurology
Medical Advisory Board for Multiple Sclerossi Society. Southwest TX Chapter
Research
Sub-Investigator:
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parrallel-Group Study of the Safety and Efficacy of a Single Treatment with Two Dose Levels of BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex. Followed by a treatment with BOTOX in patients with urinary incontinence due to neruogenic destruseor overactivity
Double-Blind, placebo-Controled, Multi-Center Study to determine the Safety and Efficacy of Gebapentin as Add-On Therapy in the Treatment of Partial Seizures
1998-2001: Targon Chronic Pain TRG004-02/03, Double Blind, Study to Determine Efficacy for once a Day Pain Medicine
1998-2001: TOPMAT-EPMN-106 (RW Johnson), Double Blind
1998-2001: BRAVO (Protocol #SB214857-030), Study to Evaluate a new Platelet Inhibitor
1988: Phase II Clinical Trial of Imuvert in Patients with Recurrent or Refractory Anaplastic Astrocytomas or Glioblastoma Multiforme
1981-1982: Resarch training, Research Assistant, Protein sequencing in chick embryo, Baylor College of Medicine
Publications
"Chronic Daily Headache Prophylaxis: Botulinum Toxin Type A Applications"
John Hopkins University School of Medicine Advanced Studies in Medicine
Vol. 6 (4D), April 2006
